-+ 0.00%
-+ 0.00%
-+ 0.00%

Truist Securities Maintains Buy on Astrana Health, Raises Price Target to $38

Benzinga·03/13/2026 17:28:13
Listen to the news
Truist Securities analyst Jailendra Singh maintains Astrana Health (NASDAQ:ASTH) with a Buy and raises the price target from $37 to $38.